Retatrutide is a new treatment in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating these receptors, Retatrutide controls cravings, {promotesglucose regulation, and ultimately results in significant slimming. While research is ongoing